Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2. | Front Genet | 2022 | 35586565 | PubTator, text mining | PubMed |
| Human T-cell lymphotropic virus type 1 (HTLV-1)-associated bronchioloalveolar disorder required differentiation from fibrotic chronic hypersensitivity pneumonitis. | Radiol Case Rep | 2022 | 35586160 | PubTator, text mining | PubMed |
| Hoxb5 reprogrammes murine multipotent blood progenitors into haematopoietic stem cell-like cells. | Cell Prolif | 2022 | 35582777 | PubTator, text mining | PubMed |
| ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer. | Sci Rep | 2022 | 35581263 | PubTator, text mining | PubMed |
| CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma. | Front Oncol | 2022 | 35574406 | PubTator, text mining | PubMed |
| Stem Cells, Hematopoiesis and Lineage Tracing: Transplantation-Centric Views and Beyond. | Front Cell Dev Biol | 2022 | 35573680 | PubTator, text mining | PubMed |
| Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC. | Front Immunol | 2022 | 35572559 | PubTator, text mining | PubMed |
| Innate Lymphoid Cells: Role in Immune Regulation and Cancer. | Cancers (Basel) | 2022 | 35565201 | PubTator, text mining | PubMed |
| Potential Biomarkers and Drugs for Nanoparticle-Induced Cytotoxicity in the Retina: Based on Regulation of Inflammatory and Apoptotic Genes. | Int J Environ Res Public Health | 2022 | 35565057 | PubTator, text mining | PubMed |
| Immune and Inflammatory Networks in Myocardial Infarction: Current Research and Its Potential Implications for the Clinic. | Int J Mol Sci | 2022 | 35563605 | PubTator, text mining | PubMed |
| Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma. | Front Genet | 2022 | 35547260 | PubTator, text mining | PubMed |
| Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment. | BMC Genomics | 2022 | 35545758 | PubTator, text mining | PubMed |
| Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls. | Res Pharm Sci | 2022 | 35531136 | PubTator, text mining | PubMed |
| Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA. | J Immunol Res | 2022 | 35528617 | PubTator, text mining | PubMed |
| Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms. | Ann Hematol | 2022 | 35525883 | PubTator, text mining | PubMed |
| Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma. | Genes Immun | 2022 | 35525858 | PubTator, text mining | PubMed |
| Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes. | Front Pharmacol | 2022 | 35517798 | PubTator, text mining | PubMed |
| The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies. | Front Pharmacol | 2022 | 35517781 | PubTator, text mining | PubMed |
| Accurate Machine Learning Model to Diagnose Chronic Autoimmune Diseases Utilizing Information From B Cells and Monocytes. | Front Immunol | 2022 | 35515003 | PubTator, text mining | PubMed |
| Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma. | J Inflamm Res | 2022 | 35509325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=47